Anna Hahn-Fogdell
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Associations of prenatal exposure to maternal autoimmune disorders with a wide spectrum of psychiatric and neurodevelopmental disorders in offspring-a nationwide cohort study.
Journal: Human reproduction open
Published: July 14, 2025
COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab.
Journal: Annals of neurology
Published: February 20, 2024
Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 08, 2023
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
Journal: Brain : a journal of neurology
Published: February 23, 2023
Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus.
Journal: Rheumatology (Oxford, England)
Published: September 21, 2022
COVID-19 clinical outcomes and DMT of MS patients and population-based controls.
Journal: Annals of clinical and translational neurology
Published: June 27, 2022
Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort.
Journal: Multiple sclerosis and related disorders
Published: April 05, 2022
Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis.
Journal: Journal of neuroimmunology
Published: March 19, 2022
Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon beta.
Journal: Multiple sclerosis and related disorders
Published: March 09, 2022
A Genetic Association Test Accounting for Skewed X-Inactivation With Application to Biotherapy Immunogenicity in Patients With Autoimmune Diseases.
Journal: Frontiers in medicine
Published: January 17, 2022
Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment.
Journal: BMJ neurology open
Published: January 17, 2022
Last Updated: 09/26/2026